Literature DB >> 15196727

Cumulative pregnancy rates after transfer of fresh and thawed embryos.

F Ubaldi1, L Rienzi, E Baroni, S Ferrero, M Iacobelli, M G Minasi, F Sapienza, F Martinez, R Anniballo, L Cobellis, J Tesarik, E Greco.   

Abstract

Frozen-thawed embryo transfer is an effective procedure that allows further possibilities of pregnancy in addition to those obtained after the fresh in vitro fertilization (IVF). In our follow-up study we analysed all fresh embryo transfer procedures and every frozen-thawed embryo transfer performed from January 2000 to December 2001 evaluating the cumulative pregnancy rates. The study population was divided into two groups according to the female age: <38 years (group I) and >38 years (group II). All the best embryos were chosen for transfer and all the supernumerary good quality embryos were cryopreserved on the day of transfer. The embryos were then thawed and manipulated using a new technique. In group I, 527 patients (619 cycles) underwent fresh embryo transfer and in 232 of them (238 cycles) the embryos were frozen (44% per patients and 38.4% per cycle). In group II, 156 patients (193 cycles) underwent fresh embryo transfer and in 14 of them (15 cycles) the embryos were frozen (9% per patient and 7.8% per cycle). The pregnancy rate of group I patients that had their supernumerary embryos frozen (232 patients and 238 cycles) was 47.4% per cycle and 48.7% per patient whereas in the same population of group II patients (14 patients and 15 cycles) the clinical pregnancy rate was 35.7% per cycle and 38.5% per patients. The cumulative clinical pregnancy rate after transfer of fresh and thawed embryos was: group I, 74% per cycle and 76% per patients; group II, 42.8% per cycle and 46.1% per patient. Frozen-thawed embryo transfer is a cost-effective practice.

Entities:  

Mesh:

Year:  2004        PMID: 15196727     DOI: 10.1016/j.ejogrb.2004.01.022

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Morphokinetics analysis of embryos derived from vitrified/warmed oocytes.

Authors:  D Montjean; C Geoffroy-Siraudin; M Gervoise-Boyer; P Tourame; P Boyer
Journal:  J Assist Reprod Genet       Date:  2015-09-26       Impact factor: 3.412

2.  Can the peak E2/follicle ratio be a quantitative indicator of pregnancy outcomes following assisted reproductive cycles? A retrospective study.

Authors:  Dan Hu; Xiyuan Dong; Min Xiong; Ting Xiong; Bo Huang; Dan Zeng; Jihui Ai; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization.

Authors:  Suresh Kini; H W Raymond Li; Dave Morrell; Sue Pickering; K Joo Thong
Journal:  J Assist Reprod Genet       Date:  2010-05-14       Impact factor: 3.412

4.  Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program.

Authors:  Filippo Ubaldi; Reno Anniballo; Stefania Romano; Elena Baroni; Laura Albricci; Silvia Colamaria; Antonio Capalbo; Fabio Sapienza; Gábor Vajta; Laura Rienzi
Journal:  Hum Reprod       Date:  2010-02-25       Impact factor: 6.918

5.  Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison with vitrification of day 2 cleavage-stage embryos.

Authors:  Fengli Chi; Chengfeng Luo; Ping Yin; Ling Hong; Jingling Ruan; Meiyuan Huang; Tao Duan; Guoqing Tong
Journal:  Zygote       Date:  2013-08-22       Impact factor: 1.442

6.  Thinning and drilling laser-assisted hatching in thawed embryo transfer: A randomized controlled trial.

Authors:  Minh Tam Le; Thi Tam An Nguyen; Thi Thai Thanh Nguyen; Van Trung Nguyen; Dinh Duong Le; Vu Quoc Huy Nguyen; Ngoc Thanh Cao; Alar Aints; Andres Salumets
Journal:  Clin Exp Reprod Med       Date:  2018-09-03

Review 7.  Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update.

Authors:  Rossella Mazzilli; Alberto Vaiarelli; Lisa Dovere; Danilo Cimadomo; Nicolò Ubaldi; Susanna Ferrero; Laura Rienzi; Francesco Lombardo; Andrea Lenzi; Herman Tournaye; Filippo Maria Ubaldi
Journal:  Asian J Androl       Date:  2022 Mar-Apr       Impact factor: 3.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.